#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Toxic epidermal necrolysis Transient ischaemic attack Hairy cell leukaemia Lymphatic malformation Extraskeletal ossification Fatty acid oxidation disorder Follicle centre lymphoma follicular grade I II – III refractory Choroidal dystrophy Juvenile chronic myelomonocytic leukaemia Mitochondrial myopathy Autoimmune demyelinating disease Systemic scleroderma Gestational trophoblastic tumour Emphysema Behcet's syndrome More trials…

    Learn about Rare Diseases

    Piriformis syndrome – Life with Disease Chondrosarcoma metastatic – Trials in Disease Mucopolysaccharidosis III – Basic Information Pemphigus – Trials in Disease Ocular melanoma – Trials in Disease Breast angiosarcoma – Life with Disease Noonan syndrome – Treatment Usher’s syndrome – Life with Disease Activated PI3 kinase delta syndrome – Trials in Disease Rhabdoid tumour – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Albiglutide Rusfertide Casimersen Dobutamine Hypromellose Eculizumab Ebastine Betamethasone Dipropionate L-Lysine Acetate Etoricoxib Calcium Chloride Dihydrate Ngi226 LTI-03 AP31969 SULFATE Argipressin Gadoteridol Cefoxitin Crisantaspase Morphine Hydrochloride Tng462 More therapies…

    Learn about Your Condition

    Prostate cancer recurrent Hypothyroidism Spermatocele Osteotomy EGFR gene mutation Endometrial cancer stage I Neoplasm malignant Ocular myasthenia Infantile apnoea Retroperitoneal cancer Herpes simplex reactivation T-cell lymphoma Breast cancer metastatic Haemorrhage prophylaxis Basal cell naevus syndrome More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Lymphatic malformation

  • Study of RLY-2608 for Adults and Children with PIK3CA-Related Overgrowth and Malformations

    Recruiting

    2 1 1
    Investigated Diseases:
    • Lymphatic malformation
    • PIK3CA-activated mutation
    • PIK3CA related overgrowth spectrum
    Investigated Drugs:
    • RLY-2608
    Belgium France Germany Ireland Italy Norway +1

  • Study on Sirolimus for Treating Cervico-facial Lymphatic Malformations in Patients with Poor Prognosis

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Lymphatic malformation
    Investigated Drugs:
    • Sirolimus
    France

  • Study on the Effects of Topical Sirolimus for Lingual Microcystic Lymphatic Malformations in Children and Adults

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Lymphatic malformation
    Investigated Drugs:
    • Sirolimus
    France

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!